会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Aminothaizoles and their use as adenosine receptor antagonists
    • 氨基噻唑及其作为腺苷受体拮抗剂的用途
    • US07109202B2
    • 2006-09-19
    • US10432302
    • 2001-11-19
    • Neil J PressRoger J Taylor
    • Neil J PressRoger J Taylor
    • A61K31/427A61K31/497A61K31/4436C07D417/14C07D277/42
    • C07D231/12C07D233/56C07D249/08
    • Compounds of formula (I) in free or salt form, where A is a C6-C15 monovalent aromatic group. R1 is hydrogen, phenyl optionally substituted by one or more substituents selected from halogen, cyano, hydroxy, C1–C8-alkyl, C1–C8-haloalkyl, C1–C8-alkoxy, C1–C8-alkoxy-C1–C8-alkyl or acyloxy, or a 5- or 6-membered monovalent heterocyclic group, R2 is hydrogen, C1-C8-alkyl, acyl or CON(R3)R4, provided that R2 is C1–C8-alkyl, acyl or CON(R3)R4 when R1 is hydrogen, R3 and R4 are each independently hydrogen, or C1–C8-alkyl, together with the nitrogen atom to which they are attached denote a 5- or 6-membered heterocyclic group, and Zl, Z2, Z3 and Z4 are each independently N or CR5, at least one of them being CR5, and R5 is hydrogen, C1–C8-alkyl or C1–C8-alkoxy. The compounds are useful as adenosine receptor antagonists, particularly in the treatment of inflammatory or obstrucive airways diseases
    • 游离或盐形式的式(I)化合物,其中A是C 6 -C 15单价芳族基团。 R 1是氢,任选地被一个或多个选自卤素,氰基,羟基,C 1 -C 8 - 烷基的取代基取代的苯基, C 1 -C 8 - 卤代烷基,C 1 -C 8 - 烷氧基,C 1 -C 8 - C 1 -C 8 - 烷氧基-C 1 -C 8 - 烷基或酰氧基,或5或6元一价杂环 基团R 2是氢,C 1 -C 8 - 烷基,酰基或CON(R 3) R 4,其中R 2为C 1 -C 8 - 烷基,酰基或CON(R' 当R 1为氢时,R 3为3以及R 4为SO 4,则R 4为S 4 每个独立地是氢或C 1 -C 8 - 烷基与它们所连接的氮原子一起表示5-或6-元杂环基,Z Z 2,Z 3,Z 4和Z 4各自独立地为N或CR 5, SUP>,其中至少一个为CR 5,R 5为氢, C 1 -C 8 - 烷基或C 1 -C 8 - 烷氧基。 这些化合物可用作腺苷受体拮抗剂,特别是用于治疗炎性或阻塞性气道疾病